Metsera Weight-Loss Drug Shows ‘Excellent’ Tolerability in Study
Metsera Inc.’s next-generation weight-loss drug showed good tolerability with few participants dropping out of a mid-stage trial, adding…
Metsera calls Novo Nordisk’s new bid superior to Pfizer offer
The logos of Danish drugmaker Novo Nordisk, maker of the blockbuster diabetes and weight-loss treatments Ozempic and Wegovy…
Pfizer (PFE) earnings Q3 2025
Pfizer CEO Albert Bourla speaks during a press conference after a visit to oversee the production of the…
Pfizer files second lawsuit against Novo Nordisk, Metsera
A Pfizer logo is displayed at a research facility in the La Jolla neighborhood of San Diego, California,…
Pfizer sues Metsera, Novo Nordisk over rival obesity drug bid
Thomas Fuller | SOPA Images | Lightrocket | Getty Images Pfizer said on Friday it had filed a lawsuit against Metsera and Novo…
Jim Cramer’s top 10 things to watch in the stock market Monday
My top 10 things to watch Monday, Sept. 22 1. Wall Street was heading for a modestly lower…
Stock market today: Live updates
Traders work on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., Sept.…